List of Signant Health Patient Engagement Customers
Blue Bell, 19422, PA,
United States
Since 2010, our global team of researchers has been studying Signant Health Patient Engagement customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Signant Health Patient Engagement for Customer Engagement from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Signant Health Patient Engagement for Customer Engagement include: Pfizer, a United States based Life Sciences organisation with 81000 employees and revenues of $63.63 billion, University Hospital Basel, a Switzerland based Healthcare organisation with 8183 employees and revenues of $1.72 billion and many others.
Contact us if you need a completed and verified list of companies using Signant Health Patient Engagement, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Signant Health Patient Engagement customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Pfizer | Life Sciences | 81000 | $63.6B | United States | Signant Health | Signant Health Patient Engagement | Customer Engagement | 2020 | n/a |
In 2020, Pfizer deployed Signant Health Patient Engagement for its global COVID-19 vaccine program. The Signant Health Patient Engagement implementation focused on capturing reactogenicity, safety, and PRO data across more than 40,000 participants in multiple countries, covering regions including the US and Europe, and it aligned with clinical operations and participant engagement workflows within the Customer Engagement category.
The deployment used Signant Patient Engagement modules TrialGuide and SmartSignals to deliver eCOA and integrated patient engagement capabilities. Configuration emphasized remote visit workflows, automated participant communications, and real time symptom and safety reporting, with the application name Signant Health Patient Engagement used to orchestrate survey delivery and event driven engagement across devices.
Signant supported integrated eCOA and patient engagement functionality to enable remote data capture and centralized monitoring across international sites. Operational coverage included participant enrollment, remote visits, safety monitoring, and retention activities across US and European study sites, enabling continuous data streams for clinical operations teams and site coordinators.
Rollout was coordinated with Pfizer clinical teams to align engagement messaging and remote visit cadence across regions, with governance focused on protocol adherence and participant communications. The deployment improved data capture speed and study retention for the vaccine program, demonstrating Signant Health Patient Engagement as a Customer Engagement platform in large scale vaccine studies.
|
 |
University Hospital Basel | Healthcare | 8183 | $1.7B | Switzerland | Signant Health | Signant Health Patient Engagement | Customer Engagement | 2021 | n/a |
In 2021, University Hospital Basel implemented Signant Health Patient Engagement to support electronic Neurostatus-EDSS assessments within its multiple sclerosis clinical trial programs. The deployment positioned Signant Health Patient Engagement as part of the hospital’s Customer Engagement ecosystem for clinical data collection and clinician-facing eCOA workflows used by research teams and site raters.
The implementation delivered an electronic Neurostatus-EDSS module that captured structured clinician-rated disability scores through standardized eCOA forms and assessment logic. Configuration aligned assessment fields, scoring rubrics, and time-stamped entries to reduce inter-rater variability, while the Signant Health Patient Engagement platform provided clinician-facing interfaces for in-clinic and site-based data entry.
Operational scope covered University Hospital Basel research teams running multiple sclerosis trials and site-level assessments, with the rollout coordinated alongside clinical investigators and raters. Governance emphasized standardized scoring protocols and centralized data quality checks to ensure consistent application of Neurostatus criteria across sites and raters.
Outcomes documented in the case study include reduced scoring variability and improved data quality in site assessments following adoption of the electronic Neurostatus-EDSS within Signant Health Patient Engagement, supporting more consistent disability scoring in the hospital’s MS trial operations.
|
Buyer Intent: Companies Evaluating Signant Health Patient Engagement
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||